StockSelector.com
  Research, Select, & Monitor Sunday, September 27, 2020 3:51:11 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Onconova Therapeutics, Inc.$0.29($.01)(3.23%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Onconova Therapeutics, Inc. has an overall rank of 6954 out of 7571 stocks based on 5 positive rankings and 8 negative rankings.

Positive Rankings
Estimated Revenue Growth
Onconova Therapeutics rank is 143
10 Day Gain
Onconova Therapeutics rank is 186
Historic Revenue Growth
Onconova Therapeutics rank is 564
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Onconova Therapeutics is ranked 838.
Debt-to-Equity
Onconova Therapeutics rank is 1993
Negative Rankings
Negative Cash Growth
Onconova Therapeutics rank is 8
Negative Net Margin
Onconova Therapeutics rank is 209
Negative ROE
Onconova Therapeutics rank is 213
Negative ROA
Onconova Therapeutics rank is 302
Price-to-Sales
Onconova Therapeutics rank is 321
Down EPS Surprise
Onconova Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
90 Day Loss
Onconova Therapeutics rank is 603
Price-to-Book
Onconova Therapeutics rank is 1427







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.